MTI-301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MTI-301, covering 2026-03-19 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers [Phase 1]